Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)
Public ClinicalTrials.gov record NCT05018416. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Open-Labeled, Repeat Dose, Safety and Efficacy Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)
Study identification
- NCT ID
- NCT05018416
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Prokidney
- Industry
- Enrollment
- 53 participants
Conditions and interventions
Interventions
- Renal Autologous Cell Therapy (REACT) Biological
Biological
Eligibility (public fields only)
- Age range
- 30 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 26, 2021
- Primary completion
- May 19, 2025
- Completion
- May 19, 2025
- Last update posted
- Mar 12, 2026
2021 – 2025
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kidney Associates of Colorado, P.C. - Frenova | Denver | Colorado | 80210-5073 | — |
| Nephrology Associates | Newark | Delaware | 19713 | — |
| Boise Kidney and Hypertension Institute - Frenova | Nampa | Idaho | 83687 | — |
| Paragon Health, PC d/b/a Nephrology Center, PC - Frenova | Kalamazoo | Michigan | 49007-3889 | — |
| Nephrology and Hypertension Associates Ltd - Frenova | Tupelo | Mississippi | 38801-6560 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05018416, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 12, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05018416 live on ClinicalTrials.gov.